Press releases from Senexis

2008

• Senexis and O2H announce medicinal chemistry collaboration Download PDF
• Senexis joins EU Alzheimer's Consortium Download PDF
• Senexis raises £3.7 million from the Wellcome Trust and BTG to further develop its small  molecule Alzheimer’s compounds Download PDF

2007

• Senexis and DanioLabs announce collaboration on ageing-related diseases Download PDF

2006

• Senexis appoints SC Consulting as its Representative in Japan Download PDF
• Prof. Dame Nancy Rothwell, FRS, joins Senexis Scientific Advisory Board Download PDF
• BTG Licenses Alzheimer's Compounds To Senexis And Co-Invests £1 Million With The Wellcome Trust Download PDF

2005

• Senexis and BioFocus collaborate to select development candidates for Senexis' Alzheimer's Disease targets Download PDF
• Senexis receives DTI GRAD award from EEDA to develop assays for the discovery of novel Diabetes drugs Download PDF
• Senexis collaborates with NeuroSolutions to test novel compounds for the treatment of Alzheimer's Disease Download PDF
• Senexis enters collaboration with BioFocus Plc to develop novel "small molecules" for the treatment of Alzheimer's Disease Download PDF

2004

• Senexis appoints Chairman and Chief Scientific Officer Download PDF

2003

• Bionow Awards 2003 Download PDF
• BTG Invests in Senexis Download PDF